Related Experiment Video
Updated: Aug 8, 2026

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
Nuclear phosphoinositide signalling enzyme in human B lymphoid cells
A Cataldi1, R Di Pietro, I Robuffo
1Istituto di Morfologia Umana Normale, Università G. D'Annunzio, Chieti, Italy.
Insights
Interferon treatment increases phosphoinositidase C (PIC) beta activity in Burkitt lymphoma cells, suggesting nuclear PIC beta 1 recruitment mediates interferon's antiproliferative effects.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Interferon (IFN) is crucial for antiviral and antitumor responses.
- Phosphoinositidase C (PIC) beta enzymes play roles in cellular signaling pathways.
- Understanding IFN's mechanism in Burkitt lymphoma is vital for therapeutic development.
Purpose of the Study:
- To investigate the effect of interferon on phosphoinositidase C (PIC) beta activity, expression, and localization in Burkitt lymphoma cells.
- To elucidate the role of nuclear PIC beta 1 in interferon's antiproliferative action.
Main Methods:
- Western blotting to analyze protein expression.
- Immunocytochemistry and immunoelectronmicroscopy for cellular localization.
- Analysis of phosphatidyl-inositol-bisphosphate (PIP2) hydrolysis.
Main Results:
- Interferon treatment led to increased PIP2 hydrolysis at the nuclear level in Daudi cells.
- PIC beta 1 expression increased and was detected in the nuclear compartment upon IFN treatment.
- A resistant cell line showed no modulation of PIC beta 1 activity or PIP2 hydrolysis upon IFN treatment.
Conclusions:
- Interferon's antiproliferative effect on Burkitt lymphoma cells may involve the recruitment of nuclear PIC beta 1.
- Nuclear PIC beta 1 activity is a potential target for enhancing interferon therapy in lymphoma.
Abstract:
The modulation of phosphoinositidase C (PIC) beta activity upon interferon treatment in Burkitt lymphoma cells (Daudi) and its localization and expression have been analyzed by Western blotting, immunocytochemical and immunoelectronmicroscopy analysis. Results have disclosed an early increase of phosphatidyl-inositol-bisphosphate (PIP2) hydrolysis at nuclear level upon interferon (IFN) treatment paralleled by the evidence of an increase of PIC beta 1 expression. PIC beta 1 expression has been detected in the nuclear compartment also in a clone of Daudi cells selected for the resistance to the antiproliferative action of interferon alpha but no modulation of the enzyme has been detected upon interferon treatment. Since no changes in terms of PIP2 hydrolysis have been found at nuclear level in this selected line, we suggest that the antiproliferative action of interferon on Burkitt lymphoma cells is mediated by a possible recruitment of nuclear PIC beta 1 expression.
More Related Videos
08:38Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
Published on: October 4, 2018
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
Related Concept Videos
Regulation of Nuclear Protein Sorting
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Second Messengers
PI3K/mTOR/AKT Signaling Pathway
IP3/DAG Signaling Pathway